CA2213420A1 - Purine compounds and xanthine oxidase inhibitors - Google Patents

Purine compounds and xanthine oxidase inhibitors

Info

Publication number
CA2213420A1
CA2213420A1 CA002213420A CA2213420A CA2213420A1 CA 2213420 A1 CA2213420 A1 CA 2213420A1 CA 002213420 A CA002213420 A CA 002213420A CA 2213420 A CA2213420 A CA 2213420A CA 2213420 A1 CA2213420 A1 CA 2213420A1
Authority
CA
Canada
Prior art keywords
purine
group
compound
mmol
crystals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002213420A
Other languages
English (en)
French (fr)
Inventor
Kazuki Endo
Masahiro Imaizumi
Tomohisa Nagamatsu
Yoko Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2213420A1 publication Critical patent/CA2213420A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002213420A 1995-02-21 1996-02-21 Purine compounds and xanthine oxidase inhibitors Abandoned CA2213420A1 (en)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
JP56537/1995 1995-02-21
JP5653795 1995-02-21
JP5653695 1995-02-21
JP56536/1995 1995-02-21
JP63378/1995 1995-02-27
JP63377/1995 1995-02-27
JP6337895 1995-02-27
JP6337795 1995-02-27
JP24874095 1995-09-01
JP24873995 1995-09-01
JP248739/1995 1995-09-01
JP248740/1995 1995-09-01

Publications (1)

Publication Number Publication Date
CA2213420A1 true CA2213420A1 (en) 1996-08-29

Family

ID=27550642

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002213420A Abandoned CA2213420A1 (en) 1995-02-21 1996-02-21 Purine compounds and xanthine oxidase inhibitors

Country Status (4)

Country Link
US (1) US5990118A (https=)
EP (1) EP0811624A1 (https=)
CA (1) CA2213420A1 (https=)
WO (1) WO1996026208A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2232871T3 (es) * 1996-07-03 2005-06-01 Sumitomo Pharmaceuticals Company, Limited Nuevos derivados de purina.
ES2166270B1 (es) * 1999-07-27 2003-04-01 Almirall Prodesfarma Sa Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona.
CA2607953A1 (en) 2005-05-09 2006-11-16 Tap Pharmaceutical Products, Inc. Methods for treating nephrolithiasis
AU2011299153B2 (en) 2010-09-10 2014-10-30 Takeda Pharmaceuticals U.S.A., Inc. Methods for concomitant treatment of theophylline and febuxostat
US20210347778A1 (en) * 2018-08-30 2021-11-11 Tera Stone Co., Ltd Hydrazinopurine compound and triazolopurine compound for inhibiting xanthine oxidase
EP3950064A4 (en) * 2019-04-03 2023-01-04 Tera Stone Co., Ltd THYMINE NUCLEOBASE BASED TRIAZOLOPYRIMIDINES AND PROCESS FOR THEIR PRODUCTION
CN114796170A (zh) * 2022-06-01 2022-07-29 集美大学 对羟基苯甲醛在制备改善或治疗高尿酸血症的药物中的应用

Also Published As

Publication number Publication date
EP0811624A4 (https=) 1998-01-14
WO1996026208A1 (en) 1996-08-29
EP0811624A1 (en) 1997-12-10
US5990118A (en) 1999-11-23

Similar Documents

Publication Publication Date Title
MXPA97002488A (en) Compounds of purine and guanine as inhibitors of
US12415797B2 (en) Heterocyclic compound as CDK-HDAC double-channel inhibitor
EP0227450A2 (en) Substituted 5,6-Dialkoxyquinazoline Derivatives
CA2213420A1 (en) Purine compounds and xanthine oxidase inhibitors
EP1757610A1 (en) Condensed pyrimidine derivative and xanthine oxidase inhibitor
US5158953A (en) 2-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-ones (thiones), the preparation and use thereof
EP3586843A1 (en) Glaucocalyxin a derivative, pharmaceutically acceptable salt thereof, or pharmaceutical composition thereof and uses thereof in preparation of drugs for treating psoriasis
US12358911B2 (en) Heterocyclic comipound as CDK-HDAC dual pathway inhibitor
CN112912378B (zh) 用于抑制黄嘌呤氧化酶的肼基嘌呤化合物以及三唑并嘌呤化合物
US12351583B2 (en) Triazolopyrimidines based on thymine nucleobase and methods for producing them
EP0028031A1 (en) Novel quinazoline derivatives, a pharmaceutical composition containing such derivatives as active ingredient and a process for producing the quinazoline derivatives
US20090149452A1 (en) Xanthine oxidase inhibitor
CA1081228A (en) Oxazole, isoxazole, thiazole and isothiazole amides
EP2578588A1 (en) Novel 1,4-diazepam pde-5 inhibitor derivatives
JPH11140086A (ja) ４−置換−１Ｈ−６−オキソピラゾロ［３，４−ｄ］ピリミジン化合物及びキサンチンオキシダーゼ阻害剤
CA2140018A1 (en) Pyrimidine compounds used in the therapy
EP0877026B1 (en) Substituted 6-r-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
JPWO1996026208A1 (ja) プリン化合物及びキサンチンオキシダーゼ阻害剤
CN121471214A (zh) 一种杂环化合物、其制备方法和用途
JPH11246560A (ja) ３−置換−７Ｈ−ピラゾロ［４，３−ｅ］−１，２，４−トリアゾロ［３，４−ｃ］ピリミジン化合物及びキサンチンオキシダーゼ阻害剤
JP2000038389A (ja) ピラゾロピリミジン化合物及びキサンチンオキシダーゼ阻害剤
JPH09208467A (ja) トリアゾロプリン化合物を含有する抗腫瘍剤
JPH04279586A (ja) キサンチン誘導体
JPWO1999043674A1 (ja) 勃起不全治療薬

Legal Events

Date Code Title Description
FZDE Dead